User profiles for M. Inglese
 | Matilde IngleseGenoa, Milan, New York Verified email at mssm.edu Cited by 21537 |
Defining the clinical course of multiple sclerosis: the 2013 revisions
… M. Clanet has received consulting fees for advisory board membership from Novartis, … M.
Inglese has received research grants from Novartis Pharmaceuticals and is a consultant for …
Inglese has received research grants from Novartis Pharmaceuticals and is a consultant for …
Cognition in multiple sclerosis: State of the field and priorities for the future
Cognitive decline is recognized as a prevalent and debilitating symptom of multiple sclerosis
(MS), especially deficits in episodic memory and processing speed. The field aims to (1) …
(MS), especially deficits in episodic memory and processing speed. The field aims to (1) …
MRI in multiple sclerosis: current status and future prospects
Many promising MRI approaches for research or clinical management of multiple sclerosis (MS)
have recently emerged, or are under development or refinement. Advanced MRI …
have recently emerged, or are under development or refinement. Advanced MRI …
Multiple Sclerosis Progression and Relapse Activity in Children
…, M De Riz, P Gazzola, G Cavaletti, M Inglese… - JAMA …, 2024 - jamanetwork.com
Importance Although up to 20% of patients with multiple sclerosis (MS) experience onset
before 18 years of age, it has been suggested that people with pediatric-onset MS (POMS) are …
before 18 years of age, it has been suggested that people with pediatric-onset MS (POMS) are …
Disease‐modifying therapies and coronavirus disease 2019 severity in multiple sclerosis
…, M Filippi, M Inglese, M Lucchini, M Pozzato… - Annals of …, 2021 - Wiley Online Library
Objective This study was undertaken to assess the impact of immunosuppressive and
immunomodulatory therapies on the severity of coronavirus disease 2019 (COVID‐19) in people …
immunomodulatory therapies on the severity of coronavirus disease 2019 (COVID‐19) in people …
Diffusion tensor magnetic resonance imaging in multiple sclerosis
Objectives: To quantify, using diffusion tensor imaging (DTI), the tissue damage in lesions
and normal-appearing white matter (NAWM) from a large cohort of patients with MS and to …
and normal-appearing white matter (NAWM) from a large cohort of patients with MS and to …
Characterization of tumor necrosis factor-deficient mice
…, A Dunn, D Grail, M Inglese… - Proceedings of the …, 1997 - National Acad Sciences
Although tumor necrosis factor (TNF) initially came to prominence because of its anti-tumor
activity, most attention is now focused on its proinflammatory actions. TNF appears to play a …
activity, most attention is now focused on its proinflammatory actions. TNF appears to play a …
[HTML][HTML] Effect of SARS-CoV-2 mRNA vaccination in MS patients treated with disease modifying therapies
…, M Ponzano, M Fronza, M Del Sette, M Scialabba… - …, 2021 - thelancet.com
Background In patients with Multiple Sclerosis (pwMS) disease-modifying therapies (DMTs)
affects immune response to antigens. Therefore, post-vaccination serological assessments …
affects immune response to antigens. Therefore, post-vaccination serological assessments …
Reciprocal regulation of gastrointestinal homeostasis by SHP2 and STAT-mediated trefoil gene activation in gp130 mutant mice
NC Tebbutt, AS Giraud, M Inglese, B Jenkins… - Nature medicine, 2002 - nature.com
The intracellular signaling mechanisms that specify tissue-specific responses to the interleukin-6
(IL-6) family of cytokines are not well understood. Here, we evaluated the functions of …
(IL-6) family of cytokines are not well understood. Here, we evaluated the functions of …
[HTML][HTML] Radiologically isolated syndrome: 5-year risk for an initial clinical event
… Inglese reports personal fees from Celgene, and Vaccinex. Dr. Katz reports grants from
Acorda Therapeutics and from the National MS Society, outside the submitted work. …
Acorda Therapeutics and from the National MS Society, outside the submitted work. …